148 filings
SC 14D9
AKLI
Akili Inc
4 Jun 24
Tender offer solicitation
7:01pm
SC TO-T
Virtual Therapeutics Corp
3 Jun 24
Third party tender offer statement
5:21pm
SC TO-C
Virtual Therapeutics Corp
29 May 24
Information about tender offer
5:32pm
SC14D9C
AKLI
Akili Inc
29 May 24
Written communication relating to third party tender offer
4:05pm
SC14D9C
AKLI
Akili Inc
29 May 24
Written communication relating to third party tender offer
9:16am
8-K
ujhxvmfq
29 May 24
Entry into a Material Definitive Agreement
9:14am
8-K
krml 7yy0
14 May 24
Akili Reports First Quarter 2024 Financial Results and Provides Business Update
4:10pm
8-K
2f50wtx1vjyerfd7hwwp
30 Apr 24
Akili Announces Amended Agreement with Shionogi, Shift in Corporate Strategy and Release Date for First Quarter 2024 Financial Results
8:14am
8-K
am6pj cipi9iwxs
23 Apr 24
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:25pm
ARS
2991998zn
6 Mar 24
Annual report to shareholders
4:28pm
DEFA14A
d9hmxkjf
6 Mar 24
Additional proxy soliciting materials
4:11pm
S-8
pcn8j46k784w4z8do
29 Feb 24
Registration of securities for employees
4:47pm
8-K
hgxjre7i itea8el
29 Feb 24
Akili Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
12:00am
8-K
xzoeajd5e5njyo1r
26 Feb 24
Japanese Product Now Under Review for Nationwide Marketing Approval
9:04am
PRE 14A
jjchsf ydmhsivi695
23 Feb 24
Preliminary proxy
7:57am
8-K
z7wxgd7d xsb9
21 Feb 24
Akili Announces Release Date for Fourth Quarter and Full Year 2023
4:11pm
8-K
e9zr2x02
5 Jan 24
Departure of Directors or Certain Officers
4:17pm